Peter Malfertheiner

Active 1986–2026

259
Papers
51,122
Citations
116
h-index
253
i10-index

Citations

Citations per year for Peter Malfertheiner1979: 1 citations1987: 4 citations1988: 4 citations1989: 19 citations1990: 12 citations1991: 12 citations1992: 18 citations1993: 23 citations1994: 23 citations1995: 36 citations1996: 21 citations1997: 35 citations1998: 59 citations1999: 86 citations2000: 114 citations2001: 82 citations2002: 140 citations2003: 141 citations2004: 104 citations2005: 163 citations2006: 209 citations2007: 225 citations2008: 200 citations2009: 217 citations2010: 228 citations2011: 198 citations2012: 219 citations2013: 277 citations2014: 308 citations2015: 306 citations2016: 297 citations2017: 294 citations2018: 371 citations2019: 1,395 citations2020: 1,558 citations2021: 1,363 citations2022: 1,243 citations2023: 1,034 citations2024: 1,823 citations2025: 868 citations2026: 25 citations1980–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,436 citing papers, 15.4% of this breakdownChina: 2,221 citing papers, 14% of this breakdownItaly: 957 citing papers, 6.1% of this breakdownGermany: 955 citing papers, 6% of this breakdownUnited Kingdom: 817 citing papers, 5.2% of this breakdownJapan: 610 citing papers, 3.9% of this breakdownFrance: 516 citing papers, 3.3% of this breakdownSpain: 466 citing papers, 2.9% of this breakdownAustralia: 407 citing papers, 2.6% of this breakdownSouth Korea: 397 citing papers, 2.5% of this breakdownNetherlands: 366 citing papers, 2.3% of this breakdownCanada: 351 citing papers, 2.2% of this breakdown
0%15.4%Other 33.6%

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology14.1%
  • Immunology and Microbiology1.5%
  • Agricultural and Biological Sciences1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Engineering0.6%
  • Other4%

Topics

  • Helicobacter pylori-related gastroenterology studies14.9%
  • Gastric Cancer Management and Outcomes4.7%
  • Gastroesophageal reflux and treatments4%
  • Clostridium difficile and Clostridium perfringens research4%
  • Gut microbiota and health3.6%
  • Gastrointestinal motility and disorders3%
  • Other65.8%

Coauthors

All papers

Open in search
  1. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

    Authors: , , , , , , , , , , , , , - Gastroenterology 2017 cited by 3,368

  2. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

    Authors: , , , , , , , , , , , , , , - Gut 2022 cited by 1,352

  3. Helicobacter pylori infection

    Authors: , , , , , , , - Nature Reviews Disease Primers 2023 cited by 1,108

  4. Kyoto global consensus report onHelicobacter pylorigastritis

    Authors: , , , , , , , , , - Gut 2015 cited by 1,776

  5. European consensus conference on faecal microbiota transplantation in clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2017 cited by 1,155

  6. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

    Authors: , , , , , , , , , , , , , , , , , - Gut 2016 cited by 2,924

  7. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2024 cited by 453

  8. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 470

  9. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

    Authors: , , , , , , , , , , , , - Gut 2012 cited by 2,259

  10. Peptic ulcer disease

    Authors: , , - The Lancet 2009 cited by 1,483

  11. Helicobacter pylori World Gastroenterology Organization Global Guideline

    Authors: , , , , , , , , , , , , , - Journal of Clinical Gastroenterology 2022 cited by 178

  12. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

    Authors: , , , , , , , , - Gastroenterology 2021 cited by 181

  13. Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori -negative patients

    Authors: , , , , , , , , , , , , - Gut 2022 cited by 151

  14. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 396

  15. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics

    Authors: , , - Gastroenterology 2019 cited by 282

  16. The stomach in health and disease

    Authors: , , , , , , , , , , , , - Gut 2015 cited by 415

  17. RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates

    Authors: , , , , , , , , , , , - Gut 2024 cited by 119

  18. Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients

    Authors: , , , , , , , - Scientific Reports 2020 cited by 111

  19. Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy Individuals

    Authors: , , , , , , , - Gastroenterology 2019 cited by 171

  20. Microbial composition of tumorous and adjacent gastric tissue is associated with prognosis of gastric cancer

    Authors: , , , , , , , , , , - Scientific Reports 2023 cited by 49

  21. International consensus statement on microbiome testing in clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Juozas Kupčinskas, Ilan Youngster, Francesco Franceschi, Sahil Khanna, Maria J. G. T. Vehreschild, Alexander Link, Flavio De Maio, Edoardo Pasolli, Aitor Blanco‐Míguez, Patrizia Brigidi, Brunella Posteraro, Franco Scaldaferri, Mirjana Rajilic Stojanovic, Françis Mégraud, Peter Malfertheiner, Luca Masucci, Manimozhiyan Arumugam, Nadeem O. Kaakoush, Eran Segal, Jasmohan S. Bajaj, Rupert W. Leong, John F. Cryan, Rinse K. Weersma, Rob Knight, Francisco Guarner, Fergus Shanahan, Patrice D. Cani, Eran Elinav, Maurizio Sanguinetti, Willem M. de Vos, Emad El‐Omar, Joël Doré, Julian R. Marchesi, Herbert Tilg, Harry Sokol, Nicola Segata, Giovanni Cammarota, Antonio Gasbarrini, Gianluca Ianiro - ˜The œLancet. Gastroenterology & hepatology 2024 cited by 73

  22. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection

    Authors: , , , , , , , , - Gut 2016 cited by 216

  23. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

    Authors: , , , , , , , , , , - Gut 2006 cited by 2,248

  24. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

    Authors: , , , , , , - The Lancet 2011 cited by 516